本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2022/9/151 分钟阅读
Determination That Bacitracin for Injection, 10,000 Units/Vial and 50,000 Units/Vial, Was Withdrawn From Sale for Reasons of Safety or Effectiveness
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA or Agency) has determined that bacitracin for injection, 10,000 units/vial and 50,000 units/vial, was withdrawn from sale for reasons of safety or effectiveness. The Agency will not accept or approve abbreviated new drug applications (ANDAs) for bacitracin for injection.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →